Browsing: Homepage Slider
Keep checking back throughout the conference, we will be updating this article with the biggest news headlines from the American Association for Cancer Research (AACR) Annual Meeting 2018 (April 14–18, IL, USA).
Positive late-stage data has been announced from the KEYNOTE-054 trial, investigating KEYTRUDA® (pembrolizumab) in high-risk stage III melanoma patients.
Recent news demonstrated that a third of cancer cases in the UK could be prevented through lifestyle changes, what steps can you take as a clinician to help guide your patients lifestyle choices? Find out in this patient perspective blog.
A novel treatment strategy could overcome drug resistance in testicular cancer, find out exclusive details in this interview with study leader Janet Shipley from the ICR (London, UK).
Discover cases studies of rare recurrences after adjuvant chemotherapy in this Editorial from Future Oncology.
In this opinion piece from our Editor, Jade Parker, you can discover the top 5 breast cancer advancements of 2017.